Publications Using MCE Products

J Med Chem. (2014). Carcinogenesis. pii: bgu238. (2014). Pharm Res. (2014). Microcirculation. (2014). Inflamm Res. (2014). Apoptosis. (2014). J Physiol. (2014). Pflugers Arch. (2014). Patent 20140335186 A1. (2014). J Cell Sci. pii: jcs.163659. (2014). Am J Pathol. (2014). Biopolymers. 101(4):391-7 (2014). BMC Biol.8; 11:78 (2013). Nat Cell Biol.14(3):295-303 (2012). Antiviral Res. 99(1):6-11 (2013). J Pharm Pharmacol. 66(4):574-83 (2014). J Bioenerg Biomembr. 44(1):155-61. (2013). Eur J Nucl Med Mol Imaging. 40(11):1739-47. (2013). American Journal of Physiology-Heart and Circulatory Physiology 299, H1309-H1317 (2010). Hypertension 60, 1207-1212 (2012). PloS one 8, e56473 (2013). American Journal of Physiology-Lung Cellular and Molecular Physiology 303, L929-L938 (2012). Nature 482, 116-119 (2012). Science translational medicine 5, 196ra199-196ra199 (2013). Cancer research 73, 2574-2586 (2013). European journal of pharmacology 663, 74-79 (2011). Current Biology 23, 1514-1526 (2013). International immunopharmacology 15, 38-41 (2013). Journal of Alzheimer's Disease 21, 1005-1012 (2010). J Pharm Biomed Anal. 66:232-9.66, 232-239 (2012). Cancer research 73, 2574-2586 (2013). Clinical Cancer Research 19, 598-609 (2013). Cancer research 73, 5206-5217 (2013). Pharmacology 85, 365-371 (2010). ACS Nano. 24;8(6):5468-77(2014). Am J Physiol Lung Cell Mol Physiol.306(2):L207-15 ( 2014). Cancer Res. 74(1):15-23 (2014). PLoS One. 9(1):e85780 (2014). BMC Musculoskelet Disord. 15(1):18 (2014). Biopolymers.101(4):391-7 (2014). Mol Pain.10(1):10 (2014). Ann Hematol.(2014). Trends Pharmacol Sci. pii: S0165-6147(14)00017-0 (2014). Virology.456-457:300-9 (2014). Spectrochim Acta A Mol Biomol Spectrosc.131:347-54 (2014). Eur Urol. pii: S0302-2838(14)00396-0 (2014). Biomaterials. pii: S0142-9612(14)00440-2 (2014). ACS Nano.8(6):5468-77 (2014). DNA Repair (Amst).pii: S1568-7864(14)00121-9 (2014). Biochem Biophys Res Commun. pii: S0006-291X(14)00930-9 (2014). Chem Res Toxicol.27(6):949-51 (2014). PLoS One. 9(6):e99083 (2014). Sci Rep. 4:5411 (2014). Chem Biol Drug Des. (2014). BioMed Research International. (2014). Antimicrob Agents Chemother. pii: AAC.03534-14 (2014). Stem Cell Research (2014). Environ Toxicol Pharmacol. (2014). PLoS One. 9(7):e100985. (2014). Cell Death Dis. 5:e1338.(2014). Spectrochim Acta A Mol Biomol Spectrosc.131:347-54 (2014). Arch Virol. (2014). Nature. doi: 10.1038/nature13485 (2014). Nat Med. doi: 10.1038/nm.3610 (2014). Leukemia. doi: 10.1038/leu. (2014) Chem Biol.18(6):679-80.(2011) J Virol. pii: JVI.01867-14. (2014). Neurobiol Dis. DOI: 10.1016/j.nbd.2014.08.005. (2014). Blood Cancer J. 4:e240.(2014). Acta Neuropathol Commun. 2(1):98. (2014). Br J Pharmacol. doi: 10.1111/bph.12889. (2014). Clin Cancer Res. pii: clincanres.0902. (2014). J Steroid Biochem Mol Biol. pii: S0960-0760(14)00203-9. (2014). Antiviral Res. pii: S0166-3542(14)00255-1. (2014). J Physiol. (2014). J Virol. 88(20):11872-85. (2014). Biochem Biophys Res Commun. pii: S0006-291X(14)01696-9. (2014). J Med Chem. (2014). Science. 346(6205):1255784. (2014). J Cell Physiol. doi: 10.1002/jcp.24835. (2014). Biomed Chromatogr. (2014). Animal Feed Science and Technology.DOI: 10.1016/j.anifeedsci. (2014). PLoS One. 9(10):e110453. (2014). J Biol Chem. 289(42):28753-64.(2014). Leuk Lymphoma. 1-26. (2014). Patent US 2014/0328854 Al Patent US 2014/0328923 Al Patent US 2014/0328922 Al Patent US 2014/0328921 Al Patent US 2014/0328924 Al Patent: US 2014/0309249 AI Patent: US 2014/0309279 A1 Patent:US 2014/0303235 Al

Customer Reviews

  • New Products

  • 67 New Products Within 30 Days

  • See More >
  • PRT062607
  • "
  • PathWay: Protein Tyrosine Kinase/RTK

    Target: Syk

    PRT062607(P505-15; PRT-2607; BIIB-057) is a highly specific and potent inhibitor of Syk with IC50 of 1-2 nM; >80-fold selective for Syk than Fgr, Lyn, FAK, Pyk2 and Zap70.

  • MORE
  • Stauprimide
  • "
  • PathWay: Others

    Target: Others

    Stauprimide is a small molecule that increases the efficiency of the directed differentiation of mouse and human ESCs; interacts with NME2 and inhibits its nuclear localization.

  • MORE
  • BQ-788
  • "
  • PathWay: GPCR/G protein

    Target: Endothelin Receptor

    BQ-788 is a potent and selective endothelin receptor subtype B (ETB) antagonist with IC50 of 1.2 nM(inhibits 125I-labeled endothelin 1 (ET-1) binding to ETB receptors on human Girardi heart cells).

  • MORE
  • SB225002
  • "
  • PathWay: GPCR/G protein

    Target: CXCR

    SB225002 is a potent and selective non-peptide inhibitor of CXCR2 with IC50 of 22 nM; >150-fold selectivity over CXCR1 and four other 7-TMRs.

  • MORE